BOT - Anything but charting, page-338

Re your 1st link ...
"The data presented here indicate that local administration of CBD blocked OA pain. Prophylactic CBD treatment prevented the later development of pain and nerve damage in these OA joints. These findings suggest that CBD may be a safe, useful therapeutic for treating OA joint neuropathic pain."
,
Yet another potential biggie for CBD, but not for BOT? Technically not a skin disorder and therefore we have no licence to use Permetrex in any treatment for it? Even though at first glance it seems tailor made for it? I would happily have another substantial CR to buy Permetrex in its entirety. I could only see it adding substantially to company worth, and the SP.